AI generated suggestion: NYSE:BSX – Boston Scientific Corp. Several signals – strong financial metrics (P/FCF ratio of 17), management’s aggressive buying the stock (SEC filing), upcoming leadership change and heavy options trade flows for December 2026 – indicate a potential catalyst for NYSE:BSX – Boston Scientific Corp. Target time horizon – February 2027. At current price near $42-45, the risk/reward ratio is very favourable.
Risks: Potential merger / takeover target with unknown sale price.
Disclaimer: Not a financial advice. AI generated summary. May contain errors and/or omissions.